The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Interventional Oncology-Global Market Insights and Sales Trends 2024
Synopsis
Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.
The global Interventional Oncology market size is expected to reach US$ 2270.5 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Interventional Oncology in various end use industries. The expanding demands from the Liver Cancer, Lung Cancer, Kidney Cancer and Bone Cancer, are propelling Interventional Oncology market. Ablation Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Embolization Devices segment is estimated at % CAGR for the next seven-year period.
Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interventional Oncology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interventional Oncology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interventional Oncology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interventional Oncology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interventional Oncology covered in this report include Boston Scientific, BTG, Medtronic, Merit Medical, Terumo, Accuray, Alpinion Medical Systems, Angiodynamics and Atricure, etc.
The global Interventional Oncology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
Global Interventional Oncology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interventional Oncology market, Segment by Type:
Ablation Devices
Embolization Devices
Support Devices
Global Interventional Oncology market, by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Interventional Oncology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.
The global Interventional Oncology market size is expected to reach US$ 2270.5 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Interventional Oncology in various end use industries. The expanding demands from the Liver Cancer, Lung Cancer, Kidney Cancer and Bone Cancer, are propelling Interventional Oncology market. Ablation Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Embolization Devices segment is estimated at % CAGR for the next seven-year period.
Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Interventional Oncology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Interventional Oncology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Interventional Oncology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Interventional Oncology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Interventional Oncology covered in this report include Boston Scientific, BTG, Medtronic, Merit Medical, Terumo, Accuray, Alpinion Medical Systems, Angiodynamics and Atricure, etc.
The global Interventional Oncology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
Global Interventional Oncology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interventional Oncology market, Segment by Type:
Ablation Devices
Embolization Devices
Support Devices
Global Interventional Oncology market, by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Interventional Oncology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Interventional Oncology
1.1 Interventional Oncology Market Overview
1.1.1 Interventional Oncology Product Scope
1.1.2 Interventional Oncology Market Status and Outlook
1.2 Global Interventional Oncology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Interventional Oncology Market Size by Region (2018-2029)
1.4 Global Interventional Oncology Historic Market Size by Region (2018-2023)
1.5 Global Interventional Oncology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Interventional Oncology Market Size (2018-2029)
1.6.1 North America Interventional Oncology Market Size (2018-2029)
1.6.2 Europe Interventional Oncology Market Size (2018-2029)
1.6.3 Asia-Pacific Interventional Oncology Market Size (2018-2029)
1.6.4 Latin America Interventional Oncology Market Size (2018-2029)
1.6.5 Middle East & Africa Interventional Oncology Market Size (2018-2029)
2 Interventional Oncology Market by Type
2.1 Introduction
2.1.1 Ablation Devices
2.1.2 Embolization Devices
2.1.3 Support Devices
2.2 Global Interventional Oncology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Interventional Oncology Historic Market Size by Type (2018-2023)
2.2.2 Global Interventional Oncology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Interventional Oncology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Interventional Oncology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Interventional Oncology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Interventional Oncology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Interventional Oncology Revenue Breakdown by Type (2018-2029)
3 Interventional Oncology Market Overview by Application
3.1 Introduction
3.1.1 Liver Cancer
3.1.2 Lung Cancer
3.1.3 Kidney Cancer
3.1.4 Bone Cancer
3.1.5 Breast Cancer
3.1.6 Prostate Cancer
3.1.7 Pancreatic Cancer
3.2 Global Interventional Oncology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Interventional Oncology Historic Market Size by Application (2018-2023)
3.2.2 Global Interventional Oncology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Interventional Oncology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Interventional Oncology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Interventional Oncology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Interventional Oncology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Interventional Oncology Revenue Breakdown by Application (2018-2029)
4 Interventional Oncology Competition Analysis by Players
4.1 Global Interventional Oncology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interventional Oncology as of 2022)
4.3 Date of Key Players Enter into Interventional Oncology Market
4.4 Global Top Players Interventional Oncology Headquarters and Area Served
4.5 Key Players Interventional Oncology Product Solution and Service
4.6 Competitive Status
4.6.1 Interventional Oncology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boston Scientific
5.1.1 Boston Scientific Profile
5.1.2 Boston Scientific Main Business
5.1.3 Boston Scientific Interventional Oncology Products, Services and Solutions
5.1.4 Boston Scientific Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.1.5 Boston Scientific Recent Developments
5.2 BTG
5.2.1 BTG Profile
5.2.2 BTG Main Business
5.2.3 BTG Interventional Oncology Products, Services and Solutions
5.2.4 BTG Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.2.5 BTG Recent Developments
5.3 Medtronic
5.3.1 Medtronic Profile
5.3.2 Medtronic Main Business
5.3.3 Medtronic Interventional Oncology Products, Services and Solutions
5.3.4 Medtronic Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.3.5 Merit Medical Recent Developments
5.4 Merit Medical
5.4.1 Merit Medical Profile
5.4.2 Merit Medical Main Business
5.4.3 Merit Medical Interventional Oncology Products, Services and Solutions
5.4.4 Merit Medical Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.4.5 Merit Medical Recent Developments
5.5 Terumo
5.5.1 Terumo Profile
5.5.2 Terumo Main Business
5.5.3 Terumo Interventional Oncology Products, Services and Solutions
5.5.4 Terumo Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.5.5 Terumo Recent Developments
5.6 Accuray
5.6.1 Accuray Profile
5.6.2 Accuray Main Business
5.6.3 Accuray Interventional Oncology Products, Services and Solutions
5.6.4 Accuray Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.6.5 Accuray Recent Developments
5.7 Alpinion Medical Systems
5.7.1 Alpinion Medical Systems Profile
5.7.2 Alpinion Medical Systems Main Business
5.7.3 Alpinion Medical Systems Interventional Oncology Products, Services and Solutions
5.7.4 Alpinion Medical Systems Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.7.5 Alpinion Medical Systems Recent Developments
5.8 Angiodynamics
5.8.1 Angiodynamics Profile
5.8.2 Angiodynamics Main Business
5.8.3 Angiodynamics Interventional Oncology Products, Services and Solutions
5.8.4 Angiodynamics Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.8.5 Angiodynamics Recent Developments
5.9 Atricure
5.9.1 Atricure Profile
5.9.2 Atricure Main Business
5.9.3 Atricure Interventional Oncology Products, Services and Solutions
5.9.4 Atricure Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.9.5 Atricure Recent Developments
5.10 Baylis Medical
5.10.1 Baylis Medical Profile
5.10.2 Baylis Medical Main Business
5.10.3 Baylis Medical Interventional Oncology Products, Services and Solutions
5.10.4 Baylis Medical Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.10.5 Baylis Medical Recent Developments
5.11 Bovie Medical
5.11.1 Bovie Medical Profile
5.11.2 Bovie Medical Main Business
5.11.3 Bovie Medical Interventional Oncology Products, Services and Solutions
5.11.4 Bovie Medical Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.11.5 Bovie Medical Recent Developments
5.12 Brainlab
5.12.1 Brainlab Profile
5.12.2 Brainlab Main Business
5.12.3 Brainlab Interventional Oncology Products, Services and Solutions
5.12.4 Brainlab Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.12.5 Brainlab Recent Developments
5.13 Bsd Medical
5.13.1 Bsd Medical Profile
5.13.2 Bsd Medical Main Business
5.13.3 Bsd Medical Interventional Oncology Products, Services and Solutions
5.13.4 Bsd Medical Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.13.5 Bsd Medical Recent Developments
5.14 C. R. Bard
5.14.1 C. R. Bard Profile
5.14.2 C. R. Bard Main Business
5.14.3 C. R. Bard Interventional Oncology Products, Services and Solutions
5.14.4 C. R. Bard Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.14.5 C. R. Bard Recent Developments
5.15 C2 Therapeutics
5.15.1 C2 Therapeutics Profile
5.15.2 C2 Therapeutics Main Business
5.15.3 C2 Therapeutics Interventional Oncology Products, Services and Solutions
5.15.4 C2 Therapeutics Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.15.5 C2 Therapeutics Recent Developments
5.16 Cardiofocus
5.16.1 Cardiofocus Profile
5.16.2 Cardiofocus Main Business
5.16.3 Cardiofocus Interventional Oncology Products, Services and Solutions
5.16.4 Cardiofocus Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.16.5 Cardiofocus Recent Developments
5.17 Cook Medical
5.17.1 Cook Medical Profile
5.17.2 Cook Medical Main Business
5.17.3 Cook Medical Interventional Oncology Products, Services and Solutions
5.17.4 Cook Medical Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.17.5 Cook Medical Recent Developments
5.18 Eckert And Ziegler Bebig
5.18.1 Eckert And Ziegler Bebig Profile
5.18.2 Eckert And Ziegler Bebig Main Business
5.18.3 Eckert And Ziegler Bebig Interventional Oncology Products, Services and Solutions
5.18.4 Eckert And Ziegler Bebig Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.18.5 Eckert And Ziegler Bebig Recent Developments
5.19 Edap Tms
5.19.1 Edap Tms Profile
5.19.2 Edap Tms Main Business
5.19.3 Edap Tms Interventional Oncology Products, Services and Solutions
5.19.4 Edap Tms Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.19.5 Edap Tms Recent Developments
5.20 Elekta
5.20.1 Elekta Profile
5.20.2 Elekta Main Business
5.20.3 Elekta Interventional Oncology Products, Services and Solutions
5.20.4 Elekta Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.20.5 Elekta Recent Developments
5.21 Galil Medical
5.21.1 Galil Medical Profile
5.21.2 Galil Medical Main Business
5.21.3 Galil Medical Interventional Oncology Products, Services and Solutions
5.21.4 Galil Medical Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.21.5 Galil Medical Recent Developments
5.22 Healthtronics
5.22.1 Healthtronics Profile
5.22.2 Healthtronics Main Business
5.22.3 Healthtronics Interventional Oncology Products, Services and Solutions
5.22.4 Healthtronics Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.22.5 Healthtronics Recent Developments
5.23 Insightec
5.23.1 Insightec Profile
5.23.2 Insightec Main Business
5.23.3 Insightec Interventional Oncology Products, Services and Solutions
5.23.4 Insightec Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.23.5 Insightec Recent Developments
5.24 Medwaves
5.24.1 Medwaves Profile
5.24.2 Medwaves Main Business
5.24.3 Medwaves Interventional Oncology Products, Services and Solutions
5.24.4 Medwaves Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.24.5 Medwaves Recent Developments
5.25 Mermaid Medical
5.25.1 Mermaid Medical Profile
5.25.2 Mermaid Medical Main Business
5.25.3 Mermaid Medical Interventional Oncology Products, Services and Solutions
5.25.4 Mermaid Medical Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.25.5 Mermaid Medical Recent Developments
5.26 Microsulis Medical
5.26.1 Microsulis Medical Profile
5.26.2 Microsulis Medical Main Business
5.26.3 Microsulis Medical Interventional Oncology Products, Services and Solutions
5.26.4 Microsulis Medical Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.26.5 Microsulis Medical Recent Developments
5.27 Monteris Medical
5.27.1 Monteris Medical Profile
5.27.2 Monteris Medical Main Business
5.27.3 Monteris Medical Interventional Oncology Products, Services and Solutions
5.27.4 Monteris Medical Interventional Oncology Revenue (US$ Million) & (2018-2023)
5.27.5 Monteris Medical Recent Developments
6 North America
6.1 North America Interventional Oncology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Interventional Oncology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Interventional Oncology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Interventional Oncology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Interventional Oncology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Interventional Oncology Market Dynamics
11.1 Interventional Oncology Industry Trends
11.2 Interventional Oncology Market Drivers
11.3 Interventional Oncology Market Challenges
11.4 Interventional Oncology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
